The purpose of the Regulatory Pharmaceutical Fellowship is to expose selected candidates to one of two tracks focused on the medical and regulatory aspects of drug information dissemination or marketing. The program serves to maintain and enhance a scientific link among the Food and Drug Administration (FDA), academia, and the pharmaceutical industry.
The program also provides an opportunity for the fellow to develop an understanding of the process and practices of the FDA and the pharmaceutical industry in the delivery of drug information and the regulatory oversight of prescription drug marketing practices.
The fellowship will allow participants to have an opportunity to experience careers in the area of academia, government, and industry. Graduates of the program will be qualified to pursue career opportunities in pharmaceutical industry, FDA or academia.
The fellowship is a two-year program consisting of:
- A nine-month rotation with the Center for Drug Evaluation and Research (CDER) (Silver Spring, MD)
- A nine-month rotation at Eli Lilly and Company (Indianapolis, IN) or Ortho-McNeil Janssen Scientific Affairs, LLC (Raritan, NJ) and
- A six-month rotation with Purdue University School of Pharmacy and Pharmaceutical Sciences (Indianapolis, IN)
The program has two tracks available:
- One drug information track, offering two-year positions annually
- One drug advertising and promotion track, offering two-year positions biennially